Delivery Order SPE2DE21D7020-SPE2D625F0RUY
- Not listed
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $45,000 fixed-price delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, effective through August 14, 2025. This delivery order, which includes economic price adjustment provisions, represents Boston Scientific's continued supply of advanced cardiac intervention technologies to the federal healthcare system. The award was made without a set-aside designation, allowing Boston Scientific to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, valued at approximately $52K with a fixed-price contract that includes economic price adjustment provisions. The delivery order was issued on September 8, 2025, with an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No small business set-aside was utilized for...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp valued at $16,900 for the FARAPULSE Pulsed Field Ablation System. The contract, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. Performance will be conducted at Boston Scientific's Marlborough, Massachusetts facility, where the company manufactures advanced...
- The Defense Health Agency's Medical Supply Chain issued a delivery order valued at $92,950 on August 11, 2025, to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 18, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract utilizes no set-aside designation, allowing the award to be made through open competition. As a...
- Boston Scientific Corp was awarded a delivery order valued at $92,950.00 for the FARAPULSE Pulsed Field Ablation System on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract is fixed-price with economic price adjustment and carries no set-aside designation. The award was funded through the Defense Health Agency's Medical Supply Chain and will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The FARAPULSE system represents a...
- The Defense Health Agency's Medical Supply Chain awarded a $67.6K delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts,...
- Boston Scientific Corp was awarded a $49.8K fixed-price delivery order with economic price adjustment on July 11, 2025, for the FARAPULSE Pulsed Field Ablation System. The contract is funded through the Defense Health Agency's Medical Supply Chain program and extends through July 18, 2025. The system will be delivered to Marlborough, Massachusetts, where Boston Scientific maintains its primary operations. This delivery order is not set aside for any specific business classification and...
- This is a $52,750.00 fixed-price delivery order contract awarded to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for a FARAPULSE Pulsed Field Ablation System. The contract has an ultimate completion date of July 10, 2025 and was awarded on July 2, 2025. The contract is not set aside for any specific business type. Boston Scientific is a key supplier of advanced medical equipment and support services to federal healthcare systems, including the...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Boston Scientific Corp, doing business as Boston Scientific. The $69,800 fixed-price delivery order is for the FARAPULSE Pulsed Field Ablation System, which is a medical device used in cardiovascular procedures. The contract has an ultimate completion date of May 20, 2024. Boston Scientific is a leading manufacturer of innovative medical technologies, including implantable...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $156,223.68, is for the delivery of a FARAPULSE Pulsed Field Ablation System, a medical device used for cardiac procedures. The contract has a performance period through March 18, 2025 and is a Delivery Order under a fixed-price with economic price adjustment contract type. The...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0RUYDelivery Order
The Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $92,950 to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This delivery order, with a fixed-price contract structure that includes economic price adjustment provisions, was awarded on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a continuation of the company's role as a critical supplier of advanced cardiovascular medical technologies to the federal healthcare system, supporting the DHA's mission to provide specialized medical devices to military personnel and beneficiaries. Boston Scientific Corp, a global medical technology leader headquartered in Marlborough, Massachusetts, has established itself as a major federal contractor supplying innovative cardiovascular, interventional, and diagnostic medical equipment to federal agencies including the Department of Veterans Affairs and the Defense Health Agency. The FARAPULSE system, a pulsed field ablation technology, aligns with the company's extensive portfolio of specialized cardiovascular intervention tools. This delivery order was not set aside for specific business types, indicating that Boston Scientific competed openly in the federal marketplace. The company's substantial track record with the DHA through various Indefinite Delivery Vehicles and delivery orders demonstrates its strategic importance in maintaining continuity of supply for specialized medical technologies essential to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.0k | 8/11/25 |